Success Metrics

Active Trials
4(100%)

Phase Distribution

Ph phase_3
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
4(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

4

all time

Status Distribution
Active(4)

Detailed Status

Active, not recruiting3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
4
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 34 (100.0%)

Trials by Status

active_not_recruiting375%
recruiting125%

Recent Activity

4 active trials
Showing 4 of 4
recruitingphase_3

Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia

NCT06822790
active_not_recruitingphase_3

Study of Plozasiran (ARO-APOC3) in Adults With Severe Hypertriglyceridemia

NCT06347003
active_not_recruitingphase_3

Study of Plozasiran in Adults With Severe Hypertriglyceridemia

NCT06347016
active_not_recruitingphase_3

Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia

NCT06347133

Clinical Trials (4)

Showing 4 of 4 trials
NCT06822790Phase 3

Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia

Recruiting
NCT06347003Phase 3

Study of Plozasiran (ARO-APOC3) in Adults With Severe Hypertriglyceridemia

Active Not Recruiting
NCT06347016Phase 3

Study of Plozasiran in Adults With Severe Hypertriglyceridemia

Active Not Recruiting
NCT06347133Phase 3

Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia

Active Not Recruiting

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4